Rare genetic heterogeneity within single tumor discovered for the first time in colorectal liver metastases after liver resection.
Ontology highlight
ABSTRACT: Effective individualized treatment of patients with colorectal liver metastases (CLM) requires tumor genotyping, usually based on the analysis of one single sample per patient. Therapy failure may partially be explained by sampling errors and/or intratumoral genetic heterogeneity. We aimed to demonstrate intratumoral genetic heterogeneity in CLM and enable pathologists to select tumor tissue for genotyping. All the tumors of 86 patients who underwent liver resection for a single CLM were reviewed. Of the 86 patients, 66 patients received chemotherapy and 20 patients did not receive chemotherapy before liver resection. All the tumor areas sampled were analyzed for KRAS, BRAF, PIK3CA, and NRAS mutations. The mutational status was tested in 74 cases, 7 cases had no
SUBMITTER: Sebagh M
PROVIDER: S-EPMC5955166 | biostudies-literature | 2018 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA